Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoTSE:6568 -0.31%81 Cyclically Adjusted PB Ratio is 0.86 as of Aug. 07, 2026, which is 2% above its 10-year median of 0.84. GuruFocus rates TSE:6568 with a GF Score™ of 81/100 and a GF Value™ of 円1,295.64 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,236 Chemicals companies, KNC Laboratories Co ranks better than 74.43% on this metric.
The historical rank and industry rank for KNC Laboratories Co's Cyclically Adjusted PB Ratio or its related term are showing as below:
TSE:6568'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.73 Med: 0.84 Max: 1.01
Current: 0.84
During the past 11 years, KNC Laboratories Co's highest Cyclically Adjusted PB Ratio was 1.01. The lowest was 0.73. And the median was 0.84.
TSE:6568's Cyclically Adjusted PB Ratio is ranked better than 74.43% of 1236
companies
in the Chemicals industry
Industry Median: 1.61
vs TSE:6568: 0.84
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
KNC Laboratories Co's adjusted book value per share data of for the fiscal year that ended in Mar26 was 円1,818.956. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円1,472.46 for the trailing ten years ended in Mar26.
Shiller PE for Stocks: The True Measure of Stock Valuation
KNC Laboratories Co (TSE:6568) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
KNC Laboratories Co Cyclically Adjusted PB Ratio Related Terms
KNC Laboratories Co Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co Cyclically Adjusted PB Ratio Chart
TSE:6568 vs DOW: Cyclically Adjusted PB Ratio Comparison
For the Chemicals subindustry, KNC Laboratories Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co Cyclically Adjusted PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's Cyclically Adjusted PB Ratio falls into.
KNC Laboratories Co Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
KNC Laboratories Co's Cyclically Adjusted PB Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 0.86 mean?
KNC Laboratories Co (TSE:6568) has a Cyclically Adjusted PB Ratio of 0.86 as of Aug. 07, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on KNC Laboratories Co and its competitors. This is near median its historical median of 0.84. Over the past decade, KNC Laboratories Co's Cyclically Adjusted PB Ratio has ranged from 0.73 to 1.01. According to the industry distribution chart, KNC Laboratories Co ranks #316 out of 1236 companies in the Chemicals industry, placing it in the top 25.6%.
Is KNC Laboratories Co's Cyclically Adjusted PB Ratio too high?
KNC Laboratories Co's current Cyclically Adjusted PB Ratio of 0.86 is near median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 1.01. The Chemicals industry median Cyclically Adjusted PB Ratio is 1.61. KNC Laboratories Co's value of 0.86 is 46.6% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #316 out of 1236 companies in the Chemicals industry, which is above the industry midpoint. Overall, KNC Laboratories Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's Cyclically Adjusted PB Ratio compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #316 out of 1236 companies for Cyclically Adjusted PB Ratio. This puts KNC Laboratories Co in the upper half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.61. KNC Laboratories Co's value of 0.86 is 46.6% below this benchmark. Historically, KNC Laboratories Co's own Cyclically Adjusted PB Ratio has ranged from 0.73 to 1.01 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 1.61, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Chemicals company?
The median Cyclically Adjusted PB Ratio among Chemicals companies is 1.61, based on 1,236 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current Cyclically Adjusted PB Ratio of 0.86 is 46.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median Cyclically Adjusted PB Ratio is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current Cyclically Adjusted PB Ratio is 0.86, which is near median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, KNC Laboratories Co (TSE:6568) is currently considered Fairly Valued. The stock's GF Value™ is 円1,295.64, compared to a current price of 円1,269.00 — trading 2.1% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 0.86, which is near median its 10-year median of 0.84 and 46.6% below the Chemicals industry median of 1.61. KNC Laboratories Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For KNC Laboratories Co (TSE:6568), the current Cyclically Adjusted PB Ratio is 0.86 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (TSE:6568) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of 円1,269.00 is trading 2.1% below its estimated GF Value™ of 円1,295.64.
GuruFocus considers KNC Laboratories Co to be Fairly Valued.
Key valuation signals for TSE:6568:
Cyclically Adjusted PB Ratio: 0.86 (near median its 10-year median of 0.84)
GF Value™: 円1,295.64 vs. price of 円1,269.00 (2.1% below fair value)
Industry Position: 46.6% below the Chemicals median (#316 of 1236)
No single metric tells the full story. See the TSE:6568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6568 has been successfully added to your 
